{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:07:42Z","timestamp":1787162862043,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-024-01970-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:37:34Z","timestamp":1738226254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional characterization of novel anti-DEFA5 monoclonal antibody clones 1A8 and 4F5 in inflammatory bowel disease colitis tissues"],"prefix":"10.1007","volume":"74","author":[{"given":"Rabi","family":"Thangaiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos M.","family":"Sakwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy R.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Izban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanika S.","family":"Chirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E. K.","family":"Hildreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amosy E.","family":"M\u2019Koma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"10","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1086\/503747","volume":"193","author":"P Kelly","year":"2006","unstructured":"Kelly P, Bajaj-Elliott M, Katubulushi M, Zulu I, Poulsom R, Feldman RA, et al. Reduced gene expression of intestinal alpha-defensins predicts diarrhea in a cohort of African adults. J Infect Dis. 2006;193(10):1464\u201370.","journal-title":"J Infect Dis"},{"issue":"7","key":"1970_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jcp.2004.022426","volume":"58","author":"B Shen","year":"2005","unstructured":"Shen B, Porter EM, Reynoso E, Shen C, Ghosh D, Connor JT, et al. Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract. J Clin Pathol. 2005;58(7):687\u201394.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/gut.48.2.176","volume":"48","author":"RN Cunliffe","year":"2001","unstructured":"Cunliffe RN, Rose FR, Keyte J, Abberley L, Chan WC, Mahida YR. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut. 2001;48(2):176\u201385.","journal-title":"Gut"},{"key":"1970_CR4","first-page":"33","volume":"6","author":"AE M\u2019Koma","year":"2013","unstructured":"M\u2019Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33\u201347.","journal-title":"Clin Med Insights Gastroenterol"},{"issue":"1","key":"1970_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423\u201339.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1970_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/gidisord1010007","volume":"1","author":"AE M\u2019Koma","year":"2018","unstructured":"M\u2019Koma AE. The multifactorial etiopathogeneses interplay of inflammatory bowel disease: an overview. Gastrointest Disord. 2018;1(1):75\u2013105.","journal-title":"Gastrointest Disord"},{"issue":"9","key":"1970_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979\u201386.","journal-title":"Nat Genet"},{"issue":"6","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749\u201353.","journal-title":"Gut"},{"issue":"41","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"15374","DOI":"10.3748\/wjg.v20.i41.15374","volume":"20","author":"LM Spekhorst","year":"2014","unstructured":"Spekhorst LM, Visschedijk MC, Alberts R, Festen EA, van der Wouden EJ, Dijkstra G, et al. Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol. 2014;20(41):15374\u201381.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1970_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11894-012-0244-x","volume":"14","author":"WJ Tremaine","year":"2012","unstructured":"Tremaine WJ. Is indeterminate colitis determinable? Curr Gastroenterol Rep. 2012;14(2):162\u20135.","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"1970_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2036.2006.03159.x","volume":"25","author":"WJ Tremaine","year":"2007","unstructured":"Tremaine WJ. Review article: indeterminate colitis\u2013definition, diagnosis and management. Aliment Pharmacol Ther. 2007;25(1):13\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5 Suppl 1","key":"1970_CR12","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1097\/01.mcg.0000123991.13937.7e","volume":"38","author":"R Burakoff","year":"2004","unstructured":"Burakoff R. Indeterminate colitis: clinical spectrum of disease. J Clin Gastroenterol. 2004;38(5 Suppl 1):S41\u20133.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/DCR.0000000000001644","volume":"63","author":"OA Lavryk","year":"2020","unstructured":"Lavryk OA, Stocchi L, Shawki S, Aiello A, Church JM, Steele SR, et al. Redo IPAA after a failed pouch in patients with Crohn\u2019s disease: is it worth trying? Dis Colon Rectum. 2020;63(6):823\u201330.","journal-title":"Dis Colon Rectum"},{"issue":"24","key":"1970_CR14","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.3748\/wjg.v13.i24.3288","volume":"13","author":"SP Bach","year":"2007","unstructured":"Bach SP, Mortensen NJ. Ileal pouch surgery for ulcerative colitis. World J Gastroenterol. 2007;13(24):3288\u2013300.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1970_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179710","volume":"12","author":"AD Williams","year":"2017","unstructured":"Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M\u2019Koma AE. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS ONE. 2017;12(8): e0179710.","journal-title":"PLoS ONE"},{"issue":"3","key":"1970_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246393","volume":"16","author":"T Rana","year":"2021","unstructured":"Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, Sakwe AM, Hui N, Wang L, Yu C, Goodwin JS, Izban MG, Offodile RS, Washington MK, Ballard BR, Smoot DT, Shi XZ, Forbes DS, Shanker A, M\u2019Koma AE. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn\u2019s colitis: a new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PLoS ONE. 2021;16(3): e0246393.","journal-title":"PLoS ONE"},{"issue":"8","key":"1970_CR17","first-page":"4188","volume":"11","author":"WA Breaux","year":"2023","unstructured":"Breaux WA, Bragg MA, M\u2019Koma AE. Ubiquitous colonic ileal metaplasia consistent with the diagnosis of Crohn\u2019s colitis among indeterminate colitis cohorts. Med Res Arch. 2023;11(8):4188.","journal-title":"Med Res Arch"},{"issue":"31","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"21509","DOI":"10.1074\/jbc.M801851200","volume":"283","author":"M Rajabi","year":"2008","unstructured":"Rajabi M, de Leeuw E, Pazgier M, Li J, Lubkowski J, Lu W. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem. 2008;283(31):21509\u201318.","journal-title":"J Biol Chem"},{"issue":"6","key":"1970_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni797","volume":"3","author":"D Ghosh","year":"2002","unstructured":"Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol. 2002;3(6):583\u201390.","journal-title":"Nat Immunol"},{"issue":"3","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2353\/ajpath.2008.070755","volume":"172","author":"D Elphick","year":"2008","unstructured":"Elphick D, Liddell S, Mahida YR. Impaired luminal processing of human defensin-5 in Crohn\u2019s disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol. 2008;172(3):702\u201313.","journal-title":"Am J Pathol"},{"issue":"32","key":"1970_CR21","doi-asserted-by":"publisher","first-page":"23216","DOI":"10.1016\/S0021-9258(18)50079-X","volume":"267","author":"DE Jones","year":"1992","unstructured":"Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem. 1992;267(32):23216\u201325.","journal-title":"J Biol Chem"},{"issue":"2","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0014-5793(93)81160-2","volume":"315","author":"DE Jones","year":"1993","unstructured":"Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 1993;315(2):187\u201392.","journal-title":"FEBS Lett"},{"issue":"3","key":"1970_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0014-5793(98)00994-6","volume":"434","author":"EM Porter","year":"1998","unstructured":"Porter EM, Poles MA, Lee JS, Naitoh J, Bevins CL, Ganz T. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett. 1998;434(3):272\u20136.","journal-title":"FEBS Lett"},{"issue":"6","key":"1970_CR24","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1128\/iai.65.6.2389-2395.1997","volume":"65","author":"EM Porter","year":"1997","unstructured":"Porter EM, Liu L, Oren A, Anton PA, Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun. 1997;65(6):2389\u201395.","journal-title":"Infect Immun"},{"issue":"6","key":"1970_CR25","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1128\/iai.65.6.2396-2401.1997","volume":"65","author":"EM Porter","year":"1997","unstructured":"Porter EM, van Dam E, Valore EV, Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun. 1997;65(6):2396\u2013401.","journal-title":"Infect Immun"},{"issue":"4","key":"1970_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.peptides.2005.08.018","volume":"27","author":"H Chen","year":"2006","unstructured":"Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, et al. Recent advances in the research and development of human defensins. Peptides. 2006;27(4):931\u201340.","journal-title":"Peptides"},{"issue":"4","key":"1970_CR27","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1172\/JCI112120","volume":"76","author":"T Ganz","year":"1985","unstructured":"Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76(4):1427\u201335.","journal-title":"J Clin Invest"},{"issue":"1","key":"1970_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jso.23192","volume":"107","author":"JM Winter","year":"2013","unstructured":"Winter JM, Yeo CJ, Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol. 2013;107(1):15\u201322.","journal-title":"J Surg Oncol"},{"key":"1970_CR29","unstructured":"M\u2019Koma AE, inventor; Meharry Medical College, assignee. Methods for Diagnosing and Treating Inflammatory Bowel Disease. United States of America Patent no. US 11427852B2, 2022."},{"key":"1970_CR30","unstructured":"M\u2019Koma AE, Sakwe AM, inventors; Meharry Medical College, assignee. Targeted hd5 antibody and assay methods for diagnosing and treating inflammatory bowel disease. United States of America Patent no. US 12174200B2, 2024."},{"issue":"11","key":"1970_CR31","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1136\/gut.2003.032805","volume":"53","author":"J Wehkamp","year":"2004","unstructured":"Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn\u2019s disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53(11):1658\u201364.","journal-title":"Gut"},{"issue":"50","key":"1970_CR32","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1073\/pnas.0505256102","volume":"102","author":"J Wehkamp","year":"2005","unstructured":"Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, et al. Reduced Paneth cell alpha-defensins in ileal Crohn\u2019s disease. Proc Natl Acad Sci USA. 2005;102(50):18129\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"1970_CR33","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1016\/j.febslet.2006.08.083","volume":"580","author":"J Wehkamp","year":"2006","unstructured":"Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett. 2006;580(22):5344\u201350.","journal-title":"FEBS Lett"},{"issue":"5","key":"1970_CR34","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.4049\/jimmunol.179.5.3109","volume":"179","author":"J Wehkamp","year":"2007","unstructured":"Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, Schnabel A, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn\u2019s disease is linked to Wnt\/Tcf-4. J Immunol. 2007;179(5):3109\u201318.","journal-title":"J Immunol"},{"issue":"3","key":"1970_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2144\/000113382","volume":"48","author":"J Bordeaux","year":"2010","unstructured":"Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, et al. Antibody validation. Biotechniques. 2010;48(3):197\u2013209.","journal-title":"Biotechniques"},{"issue":"7","key":"1970_CR36","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.jprot.2012.01.030","volume":"75","author":"C Stadler","year":"2012","unstructured":"Stadler C, Hjelmare M, Neumann B, Jonasson K, Pepperkok R, Uhlen M, et al. Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy. J Proteomics. 2012;75(7):2236\u201351.","journal-title":"J Proteomics"},{"key":"1970_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.12688\/f1000research.8159.1","volume":"5","author":"W Olds","year":"2016","unstructured":"Olds W, Li J. siRNA knockdown validation 101: incorporating negative controls in antibody research. F1000Research. 2016;5:308. https:\/\/doi.org\/10.12688\/f1000research.8159.1.","journal-title":"F1000Research"},{"issue":"7","key":"1970_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2016.03.007","volume":"34","author":"CN Kanchiswamy","year":"2016","unstructured":"Kanchiswamy CN, Maffei M, Malnoy M, Velasco R, Kim JS. Fine-tuning next-generation genome editing tools. Trends Biotechnol. 2016;34(7):562\u201374.","journal-title":"Trends Biotechnol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01970-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:52:31Z","timestamp":1767199951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01970-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01970-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4843765\/v1","asserted-by":"object"}]},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved (Protocol A2018 07-005-Y3-A10) by the University of Georgia Institutional Animal Care and Use Committee (IACUC) in compliance with the Public Health Service Policy, the Guide for the Care and Use of Laboratory Animals [PMID: 11652350 and PMID: 3306146]. All procedures performed in this study involving human participants were by the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards [(8,9)]. The Institutional Review Board ethical approvals were obtained from the Meharry Medical College (IRB files # 100916AM206 and 22-08-1235) and Vanderbilt University Medical Center (IRB files # 080898 and 100581). Informed consent was obtained and participation in the study was voluntary. Samples for the included studies were obtained from the NIH-funded Digestive Disease Research Center (PI: David A. Schwartz), Vanderbilt Gastrointestinal Biospecimen Repository, and Cooperative Human Tissue Network at Vanderbilt University Medical Center (PI: Mary K. Washington), in collaboration with the Meharry Medical College Human Tissue Acquisition Shared Resource Core (PI: Billy R. Ballard).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30"}}